Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (581-590 of 1,095) with videos related to

Pageof 110
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|September 30, 2014
Interferon-free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND-C3, a Phase 2b studyStefan Zeuzem, Jean-François Dufour, Maria Buti, et al.
Cell Death & Disease|February 6, 2023
Regulation of immunological tolerance by the p53-inhibitor iASPPElliot H Akama-Garren, Paul Miller, Thomas M Carroll, et al.
Journal of Viral Hepatitis|March 27, 2007
Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patientsM Crespo, S Sauleda, J I Esteban, et al.
Plos One|May 16, 2023
Chromosome-scale genome sequence assemblies of the 'Autumn Bliss' and 'Malling Jewel' cultivars of the highly heterozygous red raspberry (Rubus idaeus L.) derived from long-read Oxford Nanopore sequence dataR Jordan Price, Jahn Davik, Felicidad Fernandéz Fernandéz, et al.
Journal of Medical Virology|June 2, 2004
The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatmentPierre Pradat, Marianne Maynard, Maria Buti, et al.
Communications Medicine|May 12, 2023
Combined COVID-19 vaccination and hepatitis C virus screening intervention in marginalised populations in SpainJeffrey V Lazarus, Marcela Villota-Rivas, Pablo Ryan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis BDarren Wong, Margaret Littlejohn, Rosalind Edwards, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 12, 2025
Hepatitis B and C Screening and Linkage to Care in Migrants From Endemic Countries in Barcelona Through a Community ActionAnna Not, Hakima Ouaarab-Essadek, Marcos Montoro, et al.
The Lancet. Gastroenterology & Hepatology|May 23, 2025
A 2024 global report on national policy, programmes, and progress towards hepatitis B elimination: findings from 33 hepatitis elimination profilesLindsey Hiebert-Suwondo, Jana Manning, Rania A Tohme, et al.
Scientific Reports|May 20, 2026
Cost-effectiveness of community interventions to promote awareness, testing and treatment of hepatitis B and C in migrant populations in CataloniaElisa Martró, Raquel Domínguez-Hernández, Venus Forero, et al.
Pageof 110

Showing results (581-590 of 1,095) with videos related to

Sort By:
Pageof 110
Liver International : Official Journal of the International Association for the Study of the Liver|September 30, 2014
Interferon-free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND-C3, a Phase 2b studyStefan Zeuzem, Jean-François Dufour, Maria Buti, et al.
Cell Death & Disease|February 6, 2023
Regulation of immunological tolerance by the p53-inhibitor iASPPElliot H Akama-Garren, Paul Miller, Thomas M Carroll, et al.
Journal of Viral Hepatitis|March 27, 2007
Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patientsM Crespo, S Sauleda, J I Esteban, et al.
Plos One|May 16, 2023
Chromosome-scale genome sequence assemblies of the 'Autumn Bliss' and 'Malling Jewel' cultivars of the highly heterozygous red raspberry (Rubus idaeus L.) derived from long-read Oxford Nanopore sequence dataR Jordan Price, Jahn Davik, Felicidad Fernandéz Fernandéz, et al.
Journal of Medical Virology|June 2, 2004
The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatmentPierre Pradat, Marianne Maynard, Maria Buti, et al.
Communications Medicine|May 12, 2023
Combined COVID-19 vaccination and hepatitis C virus screening intervention in marginalised populations in SpainJeffrey V Lazarus, Marcela Villota-Rivas, Pablo Ryan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis BDarren Wong, Margaret Littlejohn, Rosalind Edwards, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 12, 2025
Hepatitis B and C Screening and Linkage to Care in Migrants From Endemic Countries in Barcelona Through a Community ActionAnna Not, Hakima Ouaarab-Essadek, Marcos Montoro, et al.
The Lancet. Gastroenterology & Hepatology|May 23, 2025
A 2024 global report on national policy, programmes, and progress towards hepatitis B elimination: findings from 33 hepatitis elimination profilesLindsey Hiebert-Suwondo, Jana Manning, Rania A Tohme, et al.
Scientific Reports|May 20, 2026
Cost-effectiveness of community interventions to promote awareness, testing and treatment of hepatitis B and C in migrant populations in CataloniaElisa Martró, Raquel Domínguez-Hernández, Venus Forero, et al.
Pageof 110